Linked Life Data

12149220

Source:http://linkedlifedata.com/resource/pubmed/id/12149220

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12149220rdf:typepubmed:Citationlld:pubmed
pubmed-article:12149220lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0079784lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0596901lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0017638lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0024432lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0524466lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0020964lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C1261381lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0205253lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:12149220lifeskim:mentionsumls-concept:C0205373lld:lifeskim
pubmed-article:12149220pubmed:issue4lld:pubmed
pubmed-article:12149220pubmed:dateCreated2002-7-31lld:pubmed
pubmed-article:12149220pubmed:abstractTextCloned T9-C2 glioma cells transfected with membrane macrophage colony-stimulating factor (mM-CSF) never formed subcutaneous tumors when implanted into Fischer rats, whereas control T9 cells did. The T9-C2 cells were completely killed within 1 day through a mechanism that resembled paraptosis. Vacuolization of the T9-C2 cell's mitochondria and endoplasmic reticulum started within 4 hours after implantation. By 24 hours, the dead tumor cells were swollen and terminal deoxynucleotide transferase-mediated dUTP nick-end labeling (TUNEL)-positive. Bcl2-transduced T9-C2 cells failed to form tumors in rats. Both T9 and T9-C2 cells produced cytokine-induced neutrophil chemoattractant that recruited the granulocytes into the tumor injection sites, where they interacted with the tumor cells. Freshly isolated macrophages killed the T9-C2 cells in vitro by a mechanism independent of phagocytosis. Nude athymic rats treated with antiasialo GM1 antibody formed T9-C2 tumors, whereas rats treated with a natural killer cell (NK)-specific antibody failed to form tumors. When treated with antipolymorphonuclear leukocyte (anti-PMN) and antimacrophage antibodies, 80% of nude rats formed tumors, whereas only 40% of the rats developed a tumor when a single antibody was used. This suggests that both PMNs and macrophages are involved in the killing of T9-C2 tumor cells. Immunocompetent rats that rejected the living T9-C2 cells were immune to the intracranial rechallenge with T9 cells. No vaccinating effect occurred if the T9-C2 cells were freeze-thawed, x-irradiated, or treated with mitomycin-C prior to injection. Optimal tumor immunization using mM-CSF-transduced T9 cells requires viable tumor cells. In this study optimal tumor immunization occurred when a strong inflammatory response at the injection of the tumor cells was induced.lld:pubmed
pubmed-article:12149220pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149220pubmed:languageenglld:pubmed
pubmed-article:12149220pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149220pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12149220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149220pubmed:statusMEDLINElld:pubmed
pubmed-article:12149220pubmed:monthAuglld:pubmed
pubmed-article:12149220pubmed:issn0006-4971lld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:BoussaidOOlld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:KimRonald CRClld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:ChenYijunYlld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:SanchezRamonRlld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:DanQinghongQlld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:XuQingchengQlld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:DelgadoChrist...lld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:ArpajirakulNe...lld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:JeffesEdward...lld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:DouglassThoma...lld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:JadusMartin...lld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:WilliamsChris...lld:pubmed
pubmed-article:12149220pubmed:authorpubmed-author:KleinmanMicha...lld:pubmed
pubmed-article:12149220pubmed:issnTypePrintlld:pubmed
pubmed-article:12149220pubmed:day15lld:pubmed
pubmed-article:12149220pubmed:volume100lld:pubmed
pubmed-article:12149220pubmed:ownerNLMlld:pubmed
pubmed-article:12149220pubmed:authorsCompleteYlld:pubmed
pubmed-article:12149220pubmed:pagination1373-80lld:pubmed
pubmed-article:12149220pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:meshHeadingpubmed-meshheading:12149220...lld:pubmed
pubmed-article:12149220pubmed:year2002lld:pubmed
pubmed-article:12149220pubmed:articleTitleLiving T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomas.lld:pubmed
pubmed-article:12149220pubmed:affiliationDiagnostic and Molecular Health Care Group, Veterans Affairs Medical Center, Long Beach, CA 90822, USA.lld:pubmed
pubmed-article:12149220pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12149220pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12149220pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12149220lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12149220lld:pubmed